Trial intelligence / Profile preview

MDMA-assisted psychotherapy for trauma-related post-traumatic stress disorder

RBR-6sq4c9Phase 2Completed

Sponsor
Instituto Plantando Consciência
Start
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of midomafetamine in post-traumatic stress disorder (PTSD), sponsored by Instituto Plantando Consciência. Started Feb 2018; status: completed.

02

Drugs

midomafetamine
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on RBR-6sq4c9.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6sq4c9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call